non-glp-1 medications GLP-1 mentioned by the WHO. The World Health Organization released its first global guideline on using GLP-1 medicines for obesity, emphasizing safe, appropriate, provider-guided care. DM for consultation 🤍 #GLP1 #WHOGuidelines # they caution that this is not equivalent to prescription GLP GLP-1 Agonists Explained: Definition, How

Description

This was observed even after controlling for weight loss, suggesting a direct joint-protective effect

Diabetes Obes Metab 2014;16:984e93

Finding new and better treatments is critically important to help people live healthier lives. If future studies can confirm these encouraging early signals, more people could be treated instead of falling through the cracks, and this is essential because it is estimated that fewer than one in four people receive treatment for ASUDs due to barriers like clinical availability and the stigma around seeking help